Portable Nanoplasmonic Imager Detects Sepsis Faster
By HospiMedica International staff writers Posted on 05 Feb 2020 |

Image: A nano-scale optical biosensor can rapidly detect sepsis (Photo courtesy of EPFL)
A highly portable device based on a nano-scale optical biosensor can rapidly detect inflammatory biomarkers in a patient's bloodstream.
Developed at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland), Hospital Universitari Vall dHebron (Barcelona, Spain), and Universitat Autònoma de Barcelona (UAB, Spain), the new device employs a gold-based metasurface that concentrates light around billions of nanoholes. Nanoparticles that capture the sepsis biomarkers procalcitonin (PCT) and C‐reactive protein (CRP) are distributed on the metasurface, and those that have captured biomarkers are trapped in the nanoholes. When an LED is applied, they partially obstruct the light passing through the perforated metasurface, allowing detection with a CMOS camera.
In field studies with a wide range of patient samples with sepsis, noninfectious systemic inflammatory response syndrome (SIRS), and healthy subjects, the device achieves an outstanding limit of detection of 21.3 pg mL−1 for PCT and 36 pg mL−1 for CRP. The results were validated against clinical diagnosis and currently used immunoassays, providing a performance level equivalent to the gold‐standard laboratory tests. Importantly, the plasmonic imager can enable identification of PCT levels typical of sepsis and SIRS patients in less than 15 minutes. The study was published on January 23, 2020, in Small.
“The device proved to be particularly suitable for on‐site operation due to its portability, inexpensive off‐the‐shelf optical components, and because it does not involve any moving parts or complex microfluidic elements prone to clogging,” concluded lead author Alexander Belushkin, PhD, of the EPFL Institute of BioEngineering, and colleagues. “Importantly, the sensor chips and bioassay reagents can be stored in the fridge stably over weeks and unlike previously reported optical detection schemes, do not require fluorescent tags that can be expensive, unstable, and difficult to produce.”
Sepsis is the primary cause of death in hospitals, and one of the ten leading causes of death worldwide, claiming a life every four seconds. It is associated with the body's inflammatory response to a bacterial infection and progresses extremely rapidly: every hour that goes by before it is properly diagnosed and treated increases the mortality rate by nearly 8%. Time is critical with sepsis, but the tests currently used in hospitals can take up to 72 hours to provide a diagnosis.
Related Links:
Ecole Polytechnique Fédérale de Lausanne
Hospital Universitari Vall dHebron
Universitat Autònoma de Barcelona
Developed at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland), Hospital Universitari Vall dHebron (Barcelona, Spain), and Universitat Autònoma de Barcelona (UAB, Spain), the new device employs a gold-based metasurface that concentrates light around billions of nanoholes. Nanoparticles that capture the sepsis biomarkers procalcitonin (PCT) and C‐reactive protein (CRP) are distributed on the metasurface, and those that have captured biomarkers are trapped in the nanoholes. When an LED is applied, they partially obstruct the light passing through the perforated metasurface, allowing detection with a CMOS camera.
In field studies with a wide range of patient samples with sepsis, noninfectious systemic inflammatory response syndrome (SIRS), and healthy subjects, the device achieves an outstanding limit of detection of 21.3 pg mL−1 for PCT and 36 pg mL−1 for CRP. The results were validated against clinical diagnosis and currently used immunoassays, providing a performance level equivalent to the gold‐standard laboratory tests. Importantly, the plasmonic imager can enable identification of PCT levels typical of sepsis and SIRS patients in less than 15 minutes. The study was published on January 23, 2020, in Small.
“The device proved to be particularly suitable for on‐site operation due to its portability, inexpensive off‐the‐shelf optical components, and because it does not involve any moving parts or complex microfluidic elements prone to clogging,” concluded lead author Alexander Belushkin, PhD, of the EPFL Institute of BioEngineering, and colleagues. “Importantly, the sensor chips and bioassay reagents can be stored in the fridge stably over weeks and unlike previously reported optical detection schemes, do not require fluorescent tags that can be expensive, unstable, and difficult to produce.”
Sepsis is the primary cause of death in hospitals, and one of the ten leading causes of death worldwide, claiming a life every four seconds. It is associated with the body's inflammatory response to a bacterial infection and progresses extremely rapidly: every hour that goes by before it is properly diagnosed and treated increases the mortality rate by nearly 8%. Time is critical with sepsis, but the tests currently used in hospitals can take up to 72 hours to provide a diagnosis.
Related Links:
Ecole Polytechnique Fédérale de Lausanne
Hospital Universitari Vall dHebron
Universitat Autònoma de Barcelona
Latest Critical Care News
- Highly Sensitive On-Skin Sensing Monitor Detects Vitamin B6 and Glucose in Sweat
- Artificial Intelligence Revolutionizing Pediatric Anesthesia Management
- New Device Detects Tuberculosis DNA Directly in Exhaled Air
- New Menstrual Cup Could Detect Infections and Improve Diagnostics
- Engineered “Natural Killer” Cells Could Help Fight Cancer
- Faster Lymph Flow Predicts Better Response to Diuretics in Acute Heart Failure
- New Global Recommendations Aim to End Deaths from Postpartum Hemorrhage
- 'Flat-Line ECG' Indicates Poor Outcomes for Out-Of-Hospital Cardiac Arrest
- New Guidance to Improve Diagnosis and Management of Heart Failure During Pregnancy and Postpartum
- Unified Framework Establishes New Global Standard for Precision Medicine in Sepsis and Critical Care
- Cold Plasma Penetrates Deep into Tissue to Fight Cancer
- Radioactive Microscopic Beads Could Treat Patients with Kidney Cancer
- First-Ever Medical Technology Regrows Nerves and Stops Amputations in Diabetic Patients
- AI Tool Reduces Serious Complications and Readmissions After Colorectal Cancer Surgery
- Time-Released Gel Eliminates Residual Brain Tumor Cells Post Resection
- Handheld Sensor Could Replace Blood Tests for Health Monitoring
Channels
Critical Care
view channel
Highly Sensitive On-Skin Sensing Monitor Detects Vitamin B6 and Glucose in Sweat
Vitamin B6 plays a crucial role in immune function and brain health, yet patients with chronic conditions such as diabetes often experience deficiencies that can cause irritability, depression, anemia,... Read more
Artificial Intelligence Revolutionizing Pediatric Anesthesia Management
Administering anesthesia to children poses unique challenges, as their anatomy varies significantly even among patients of the same age. Misjudging the correct breathing tube size or failing to detect... Read moreSurgical Techniques
view channel
Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
Implant-associated infections remain one of the biggest challenges in orthopedic surgery, leading to device failure, prolonged recovery, and increased antibiotic resistance. Conventional implant materials... Read more
Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
Pancreatic ductal adenocarcinoma (PDAC) is the most common and deadliest form of pancreatic cancer, ranking as the third leading cause of cancer-related deaths worldwide. Current tumor ablation techniques—using... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more